SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001104659-14-073411
Filing Date
2014-10-23
Accepted
2014-10-23 16:24:25
Documents
6

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY REVISED PROXY SOLICITING MATERIALS a14-14205_6prer14a.htm PRER14A 455236
3 GRAPHIC g142056cai001.gif GRAPHIC 89860
4 GRAPHIC g142056cai002.gif GRAPHIC 18019
5 GRAPHIC g142056bci001.jpg GRAPHIC 6023
6 GRAPHIC g142056bgi001.jpg GRAPHIC 4789
7 filename7.htm CORRESP 14450
  Complete submission text file 0001104659-14-073411.txt   634872
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: PRER14A | Act: 34 | File No.: 000-55020 | Film No.: 141170241
SIC: 2834 Pharmaceutical Preparations